Xylem affirms FY2026 adjusted EPS and sales guidance range
Xylem affirms FY2026 adjusted EPS guidance of $5.55–$5.70 versus a $5.54 analyst estimate, and affirms FY2026 sales guidance of $9.200B versus a $9.254B estimate.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.